At meeting held on 30 January 2015
Aarti Drugs announced that the Board of Directors of the Company at its meeting held on 30 January 2015, inter alia, has approved the following subject to necessary approvals of Company's shareholders which would be obtained through Postal Ballot & E-Voting:1. Increase of Authorized Share Capital & consequent alteration of Memorandum of Association: Authorized Share Capital of the Company will be increased from Rs. 21,50,00,000 to Rs. 25,00,00,000 and consequent alteration of Clause V of Memorandum of Association of the Company;
2. Announcement of Bonus Equity Shares: Announcement of Bonus Equity Shares by capitalization of reserves & surplus including securities premium account to the existing shareholders of the Company in proportion of 1:1 i.e. 1 (one) bonus equity share of Rs. 10 each fully paid up for every 1 (one) existing equity share of Rs. 10 each fully paid up held in the Company on the 'Record Date' to be fixed in this behalf in due course.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
